1. Home >
  2. M&A >
  3. Stake Purchase >
  4. India >
  5. CX Partners Invests In Dindigul Thalappakatti

Investment Summary

CX Partners Invests In Dindigul Thalappakatti

On October 21, 2019, private equity firm CX Partners invested in restaurant Dindigul Thalappakatti

Investment Highlights
  • This is CX Partners’ 1st transaction in the Restaurants sector.
  • This is CX Partners’ 10th transaction in India.

Investment Summary
Date 2019-10-21
Target Dindigul Thalappakatti
Sector Restaurants
Investor(s) CX Partners
Deal Type Stake Purchase

Target

Dindigul Thalappakatti

Chennai, India
Dindigul Thalappakatti is a South Indian non-vegetarian restaurant chain with 64 restaurants in India and six other countries (as of December 2019). The brand has a 60-year-old heritage and is known for providing authentic, consistent, and quality food at affordable price points. Dindigul Thalappakatti was founded in 1957 and is based in Chennai, India.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

CX Partners

New Delhi, India

Investor Investor Investor Investor

Category Private Equity Firm
Founded 2009
PE ASSETS 625M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

CX Partners is a private equity firm specializing in middle-market growth capital and special situations investments throughout India. CX Partners was founded 2009 and is based in New Delhi.

DEAL STATS #
Overall 11 of 13
Sector (Restaurants) 1 of 1
Type (Stake Purchase) 6 of 6
Country (India) 10 of 12
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-07 Veeda

Ahmedabad, India

Veeda is a provider of clinical studies including healthy volunteers and patient trials for Generics, NCE, and Biopharmaceuticals. Veeda was founded in 2004 and is based in Ahmedabad, India.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-01 Sekhmet Pharmaventures

Mumbai, India

Sekhmet Pharmaventures plans to acquire controlling stakes in multiple Active Pharmaceutical Ingredient (API) businesses. Sekhmet Pharmaventures is based in Mumbai, Maharashtra.

Buy -
Mergr

Product

Company

Legal